adalimumab

English

Etymology

From ada- (of unknown origin) +‎ -lim- (“immunomodulating”) +‎ -umab (“human monoclonal antibody”).

Pronunciation

Noun

adalimumab (uncountable)

  1. (pharmacology) An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.

Translations

References

This article is issued from Wiktionary. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.